音声再建デバイスの世界市場-2022-2029

市場の概要

音声再建デバイスの世界市場は、2021年に5億3129万米ドル、2029年には6億275万米ドルに達し、予測期間（2022～2029年）にCAGR9.58%で成長すると予測されます。

音声再建デバイスは、食道発声や親指によるストマ閉塞などの音声療法とともに使用され、喉頭摘出患者の発声を支援するものです。多くの場合、喉頭がんにより声帯を摘出します。その場合、デバイスやインプラントを用いた特定の音声回復療法を受ける必要があります。

市場力学

これらの音声回復装置に対する需要の増加、喉頭がんの発生率の上昇、研究開発費の増加、新規製品の上市の増加が市場の成長を促進すると予想されます。

音声再建デバイスの新規製品発売と需要の増加が、市場成長の原動力となるでしょう。

音声再建デバイスの世界市場は、主にヘルスケア産業における音声再建デバイスの需要の急増、製品発表数の増加、これらの電気喉頭の多くの利点によって牽引されています。音声回復に有利な新規の低侵襲性耳鼻咽喉科処置について、さまざまな研究が行われています。例えば、2021年10月、Blom-Singer音声復元などのENT製品を開発するInHealth Technology社は、Blom-Singer Speak free HMEハンズフリーバルブの発売を発表しました。この製品は、喉頭全摘術を受けた患者さんに有利に働くでしょう。

様々な最新の技術革新が行われ、音声再建デバイスの発売数は増加し、需要が高まっています。これらのデバイスの最新の技術革新は、市場の成長を促進しています。例えば、オルビサナ・ヘルスケアの製品であるサーボックス・デジタルXL電気喉頭は、声帯の活動をコピーして音声を増幅する人工声帯装置です。気管切開の手術を受けた人に有効です。音量や周波数は設定により変更可能です。

音声再建デバイスに関連する高コストは、市場の成長を阻害します。

しかし、デバイスや手順の高コストは、市場の可能性を阻害する可能性があります。様々なタイプの音声補聴器や方法が市場に出回っています。多くの中小規模のクリニックでは、予算不足のため、さまざまなブランドやサイズの装置の最小限の在庫を注文し、前払いすることができません。空気圧式人工喉頭装置の価格は約75～150米ドル、ネック型電気喉頭装置の価格は150～800米ドルと幅があります。

COVID-19の影響分析

パンデミックは、世界の金融への期待、オペレーション、危機対応戦略にマイナスの影響を及ぼしています。市場参入企業は、研究市場を活用し、パンデミックに対抗するための最先端のアイテムを生み出すことで、長期的・短期的な成長戦略を変えています。COVID-19が業界に害を与えても、事業運営のためにできるだけ早くバックアッププランを準備し、実行することが重要です。様々なコラボレーションや合併が世界中で起こっており、市場の成長を後押ししています。例えば、2022年1月、ICU Medicalは医療機器メーカーのSmith's Medicalを買収しました。

目次

第1章 市場調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 新製品発売の増加
    • 音声再建デバイスの需要増加
  • 抑制要因
    • これらのデバイスに関連する高コスト
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターの5つの力
• アンメットニーズ
• サプライチェーン分析
• 規制分析

第6章 COVID-19分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 デバイスタイプ別

• 人工喉頭（電気喉頭）
• 気管食道用人工声帯
  • プロボックス人工声帯
  • ブロムシンガープロテーゼ
  • ナイダム人工声帯
  • フローニンゲンボイスプロテーゼ

第8章 製品寿命別

• 12ヶ月以上
• 6ヶ月～12ヶ月
• 6ヶ月未満

第9章 エンドユーザー別

• 多科目専門病院
• 耳鼻咽喉科病院
• 外来手術センター

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第12章 企業プロファイル

• Atos Medical（Coloplast）
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Inhealth Technologies
• Freudenberg Medical
• Luminaud Inc.
• Romet Electronic Larynx
• Smith's Medical（ICU Medical）
• Sanova Holding AG
• Orbisana Healthcare
• Acclarent Inc.（Johnson & Johnson）
• William Demant Holdings

第13章 音声再建デバイスの世界市場-DataM

Market Overview

The global voice restoration devices market was valued at US$ 531.29 million in 2021 and is estimated to reach US$ 602.75 million by 2029, growing at a CAGR of 9.58% during the forecast period (2022-2029).

Voice restoration devices are used with voice therapy, such as esophageal speech and stoma occlusion with the thumb, to help laryngectomy patients produce a statement. In most cases, the voice box is removed due to larynx cancer. The patient has to undergo specific voice restoration therapy involving devices and implants.

Market Dynamics

The increasing demand for these voice restoration devices, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for voice restoration devices will drive market growth.

The global market for voice restoration devices is primarily driven by the surge in demand for voice restoration devices in the healthcare industry, the rising number of product launches, and the many advantages of these electrolarynxes. Various studies are being conducted on novel minimally invasive ENT procedures that benefit voice restoration. For instance, in Oct 2021, InHealth Technology, a company that develops ENT products such as Blom-Singer voice restoration, announced the launch of the Blom-Singer Speak free HME hands-free valve. This product will be advantageous for patients who have undergone total laryngectomy.

Various latest technological advancements are taking place, and the number of voice restoration device launches is increasing, increasing the demand. The latest innovations in these devices are driving the growth of the market. For instance, Orbisana Healthcare's product Servox Digital XL electrolarynx is a voice prosthesis device that copies the activity of the voice box and amplifies the speech. It can be useful for individuals got tracheotomy procedures. Volume and frequency can be changed from settings.

High costs associated with voice restoration devices will hamper the market's growth.

However, the high cost of devices and procedures might hamper the market potential. Various types of voice prostheses and methods are available in the market. Many small and medium-sized clinics cannot order and prepay for a minimum stock of different brands and sizes of devices due to a lack of budget. The price of pneumatic artificial larynx devices ranges from approximately USD 75 to USD 150, while the neck-type electrolarynx device's price varies from USD 150 to USD 800.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harms the industry, preparing and implementing backup plans as soon as possible for business operations is crucial. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jan 2022, ICU Medical acquired Smith's Medical, a medical device manufacturer.

Segment Analysis

The artificial larynx (Electrolarynx) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial larynx (Electrolarynx) segment is the highest market holder in the global voice restoration devices market. The artificial larynx (Electrolarynx) is the leading device type in the market, holding a dominant share. Electrolarynx is a vibrator that is externally operated and is placed on the chin or cheeks; that generates vibrations in the throat that are further converted into speech from the mouth of the patient. A significant advantage of the artificial larynx is that its use is often quickly and rapidly learned and is now available latest hand-free devices. The devices, specifical valves, are made of silicone in voice prosthesis and electronically operated devices in an electrolarynx. According to the NIH, in 2021, larynx cancer caused approximately 0.6% of deaths and 0.7% of new cases of all cancers globally. The novel development of innovative and advanced electrolarynx is increasing market growth. For instance, Romet Electronic Larynx introduced its Romet R700 Clarity programmable digital electronic larynx. It is a digital electrolarynx device that laryngectomy patients use. This digital device produces some mechanical vibrations having a low sound frequency of around 60-195 Hz. In the neck, these vibrations develop trembling in the oral cavity, which is the same as the human voice. Combining the starting and stopping sound vibrations with oral articulation generates human speech.

Geographical Analysis

North America holds the largest market share of the global voice restoration devices market.

North America dominates the global voice restoration devices market, primarily attributed to the increasing number of partnerships or collaborations between companies, the rising demand for voice restoration devices, and novel studies. Furthermore, factors including growing expenditure on research and development, the increasing incidence of laryngeal and hypopharyngeal cancer, and the adoption of voice restoration devices among patients will likely enhance the growth of the region's voice restoration devices market. The American Cancer Society estimated that about 12,470 new laryngeal cancer cases would be registered in the U.S. in 2022, out of which 3,820 people are expected to die from laryngeal cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For instance, in Sep 2021, Acclarent Inc, a subsidiary of Johnson & Johnson company of medical devices, developed minimally invasive ENT technologies and launched its AI-powered ENT technology. This technology simplifies surgical planning, and it provides real-time feedback during ENT navigation procedures.

Competitive Landscape

The voice restoration devices market is highly competitive with local and global companies. Atos Medical, Inhealth Technologies, Freudenberg Medical, Luminaud Inc., Romet Electronic Larynx, Smith's Medical (ICU Medical), Sanova Holding AG, Orbisana Healthcare, Acclarent Inc. (Johnson & Johnson), William Demant Holdings and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Coloplast completed the acquisition of Atos Medical, an innovative medical device developer in laryngectomy and tracheostomy, after receiving the regulatory authority's approval. This will lead to the addition of new ENT and Respiratory care in Coloplast's business segment.

Atos Medical (Coloplast):

Overview:

Atos Medical is a company that designs and commercializes innovative medical devices in laryngectomy and tracheostomy. It was founded in 1986 and is headquartered in Malmo, Sweden. Atos provides its products in around 90 countries.

Product Portfolio:

Provox ActiValve: It is a prosthesis device specially developed for patients facing early leakage problems from voice prostheses. The valve flap and ring are fluoroplastic material that prevents candida destruction. While breathing and swallowing, the inadvertent opening of the valve flap will be prevented by the magnets.

The global voice restoration devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The rising novel product launches
    • 4.1.1.2. Increasing demand for voice restoration devices
  • 4.1.2. Restraints:
    • 4.1.2.1. High cost associated with these devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces
• 5.2. Unmet Needs
• 5.3. Supply chain Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 7.1.2. Market Attractiveness Index, By Device Type
• 7.2. Artificial Larynx (Electrolarynx) *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Tracheoesophageal Voice Prosthesis
  • 7.3.1. Provox Voice Prosthesis
  • 7.3.2. Blom-Singer Prosthesis
  • 7.3.3. Nijdam Voice Prosthesis
  • 7.3.4. Groningen Voice Prosthesis

8. By Device Lifespan

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 8.1.2. Market Attractiveness Index, By Device Lifespan
• 8.2. More than 12 Months *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. 6-12 Months
• 8.4. Less than 6 Months

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Multi-Specialty Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. ENT Hospitals
• 9.4. Ambulatory Surgical Centres

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. The U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Product Benchmarking
• 11.4. List of Key Companies to Watch

12. Company Profiles

• 12.1. Atos Medical (Coloplast)
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Inhealth Technologies
• 12.3. Freudenberg Medical
• 12.4. Luminaud Inc.
• 12.5. Romet Electronic Larynx
• 12.6. Smith's Medical (ICU Medical)
• 12.7. Sanova Holding AG
• 12.8. Orbisana Healthcare
• 12.9. Acclarent Inc. (Johnson & Johnson)
• 12.10. William Demant Holdings

LIST NOT EXHAUSTIVE

13. Global Voice Restoration Devices Market- DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us